Premium
Genetic spectrum of MCM3AP and its relationship with phenotype of Charcot‐Marie‐Tooth disease
Author(s) -
Dong HaiLin,
Wei Qiao,
Li JiaQi,
Li HongFu,
Bai Ge,
Ma Huan,
Wu ZhiYing
Publication year - 2020
Publication title -
journal of the peripheral nervous system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 67
eISSN - 1529-8027
pISSN - 1085-9489
DOI - 10.1111/jns.12377
Subject(s) - missense mutation , sanger sequencing , phenotype , genetics , genotype , rna splicing , biology , genotype phenotype distinction , nonsense , microbiology and biotechnology , mutation , gene , rna
Mutations in MCM3AP have recently been reported to cause autosomal recessive Charcot‐Marie‐Tooth disease (CMT). However, only nine CMT families with MCM3AP mutations have been reported and genotype‐phenotype correlation remains unclear. This study aimed to investigate the genetic spectrum of MCM3AP and its relationship with phenotype of CMT. Whole‐exome sequencing (WES) was performed in the family and variants were validated by Sanger sequencing. Reverse transcription‐PCR (RT‐PCR) were performed in splicing analysis. We reported a novel splicing variant (c.5634‐1G>T) and a known missense variant (c.2633G>A, p.Arg878His). Functional studies showed that c.5634‐1G>T led to splicing defect and aberrant transcript eliminated by nonsense‐mediated mRNA decay. The symptom of the patient was less severe and slowly progressed with axonal peripheral neuropathy compared to the reported CMT patients. Genotype‐phenotype correlation analysis indicated that affected individuals with null mutations presented with delayed independent walking. The percentage of intellectual disability and loss of ambulation in the null group tended to be greater, although this failed to reach statistical significance. Our findings expand the genetic spectrum of MCM3AP and suggest that genotype‐phenotype correlation would help genetic counseling of MCM3AP in CMT patients.